Since establishing our private equity strategy in 1989, we have invested in over 405 private equity investments in 42 countries.
| Company | Country | Sector | Description | Deal type | Invest. date | |
|---|---|---|---|---|---|---|
 |
ICE Pharma | Country Italy | Sector Healthcare | Description A global leader in the production of Ursodeoxycholic Acid (UDCA) used for the treatment of gastric and chronic diseases | Deal type Buyout | Invest. date Sep 2019 |
 |
Zentiva | Country Czech Republic | Sector Healthcare | Description A leading European generics pharmaceutical company, offering generic medicines across all key therapeutic areas | Deal type Carve-out | Invest. date Sep 2018 |
 |
Mediq | Country Netherlands | Sector Healthcare | Description Global provider of pharmaceuticals, medical devices and related care services | Deal type Public-to-private | Invest. date Feb 2013 |
 |
Labormed | Country Romania | Sector Healthcare | Description Romanian pharmaceutical manufacturer and distributor | Deal type Buyout | Invest. date Feb 2008 |
 |
Terapia | Country Romania | Sector Healthcare | Description Romania's largest independent generic pharmaceuticals manufacturer | Deal type Public-to-private | Invest. date Aug 2003 |
 |
Aviagen | Country United Kingdom | Sector Healthcare | Description World's leading meat poultry breeding company | Deal type Buyout | Invest. date May 2003 |
 |
Viatris | Country Germany | Sector Healthcare | Description Development, manufacturing, distribution and in-licensing of branded pharmaceuticals | Deal type Carve-out | Invest. date Aug 2002 |
 |
Tropon | Country Germany | Sector Healthcare | Description Toll manufacturer and supplier of drugs for inflammatory and rheumatoid disorders (acquired by Advent portfolio company Viatris) | Deal type Carve-out | Invest. date Mar 2000 |
 |
Alcala Farma | Country Spain | Sector Healthcare | Description Manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and over-the-counter products | Deal type Growth equity | Invest. date Sep 1999 |
 |
Trinity Pharmaceuticals | Country United Kingdom | Sector Healthcare | Description Co-development, licensing and marketing of branded pharmaceuticals, mainly for cardiovascular and arthritic indications | Deal type Carve-out | Invest. date Mar 1997 |
 |
Esaote Biomedica | Country Italy | Sector Healthcare | Description Research, production and marketing of imaging and non-imaging medical diagnostic equipment | Deal type Privatization | Invest. date Jul 1994 |
© 2002-2023 Advent International Corporation. All rights reserved
